Ultrasound screening: Status of markers and efficacy of screening for structural abnormalities

Seminars in Perinatology

Volumn 40, Issue 1, 2016, Pages 67-78

  Rao, Rashmi ^a   Platt, Lawrence D ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Center for Fetal Medicine and Women's Ultrasound   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; ESTRIOL; INHIBIN;

ANEUPLOIDY; CHOROID PLEXUS; CHOROID PLEXUS CYST; CYST; DOWN SYNDROME; DUCTUS VENOSUS; ECHOGENIC BOWEL; ECHOGENIC INTRACARDIAC FOCUS; FALSE POSITIVE RESULT; FETUS DISEASE; FETUS ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; HUMAN; LONG BONE; MATERNAL AGE; MATERNAL BLOOD; NASAL BONE; NON INVASIVE MEASUREMENT; NUCHAL FOLD; NUCHAL TRANSLUCENCY MEASUREMENT; PRENATAL SCREENING; PRIORITY JOURNAL; PYELECTASIS; RADIOLOGICAL PARAMETERS; REVIEW; RISK ASSESSMENT; SECOND TRIMESTER PREGNANCY; SHORT STATURE; SINGLE UMBILICAL ARTERY; TRICUSPID VALVE REGURGITATION; TRISOMY 21; ABNORMALITIES; BLOOD FLOW VELOCITY; BRAIN DISEASE; CONGENITAL DISORDER; DIAGNOSTIC IMAGING; ECHOCARDIOGRAPHY; ECHOENCEPHALOGRAPHY; FEMALE; FEMUR; HUMERUS; INFERIOR CAVA VEIN; NOSE CARTILAGE; PREGNANCY;

ANEUPLOIDY; BLOOD FLOW VELOCITY; BRAIN DISEASES; CHOROID PLEXUS; CONGENITAL ABNORMALITIES; CYSTS; DOWN SYNDROME; ECHOCARDIOGRAPHY; ECHOENCEPHALOGRAPHY; FEMALE; FEMUR; HUMANS; HUMERUS; NASAL BONE; NASAL CARTILAGES; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PYELECTASIS; SINGLE UMBILICAL ARTERY; TRICUSPID VALVE INSUFFICIENCY; ULTRASONOGRAPHY, PRENATAL; VENA CAVA, INFERIOR;

EID: 84959167265     PISSN: 01460005     EISSN: 1558075X     Source Type: Journal    
DOI: 10.1053/j.semperi.2015.11.009     Document Type: Review

References (90)

1. Nicolaides K.H. Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities. Am J Obstet Gynecol 2004, 191(1):45-67.
2. Benson C.B., Doubilet P.M. The history of imaging in obstetrics. Radiology 2014, 273(2 suppl):S92-S110.
3. Theodore J., Dubinsky M.D. Advances in Obstetric Ultrasound 2011, 6. W. B. Saunders Company, Philadelphia, PA.
4. Reddy U.M., Abuhamad A.Z., Levine D., et al. Fetal imaging: executive summary of a joint Eunice Kennedy Shriver National Institute of Child Health and Human Development, Society for Maternal-Fetal Medicine, American Institute of Ultrasound in Medicine, American College of Obstetricians and Gynecologists, American College of Radiology, Society for Pediatric Radiology, and Society of Radiologists in Ultrasound Fetal Imaging Workshop. J Ultrasound Med 2014, 33(5):745-757.
5. Greenberg Raymond S., SRD, Flanders W.Dana, Eley John William, Boring John R. Medical Epidemiology 2005, The McGraw-Hill Companies. 4th ed.
6. Long G., Sprigg A. A comparative study of routine versus selective fetal anomaly ultrasound scanning. J Med Screen 1998, 5(1):6-10.
7. Crane J.P., LeFevre M.L., Winborn R.C., et al. A randomized trial of prenatal ultrasonographic screening: impact on the detection, management, and outcome of anomalous fetuses. The RADIUS Study Group. Am J Obstet Gynecol 1994, 171(2):392-399.
8. Grandjean H., Larroque D., Levi S. The performance of routine ultrasonographic screening of pregnancies in the Eurofetus Study. Am J Obstet Gynecol 1999, 181(2):446-454.
9. Levi S. Ultrasound in prenatal diagnosis: polemics around routine ultrasound screening for second trimester fetal malformations. Prenat Diagn 2002, 22(4):285-295.
10. Bulletins A.C.O.P. ACOG Practice Bulletin No. 77: screening for fetal chromosomal abnormalities. Obstet Gynecol 2007, 109(1):217-227.
11. Sladkevicius P., Saltvedt S., Almstrom H., Kublickas M., Grunewald C., Valentin L. Ultrasound dating at 12-14 weeks of gestation. A prospective cross-validation of established dating formulae in in-vitro fertilized pregnancies. Ultrasound Obstet Gynecol 2005, 26(5):504-511.
12. American College of Obstetricians and Gynecologists ACOG Practice Bulletin No. 101: ultrasonography in pregnancy. Obstet Gynecol 2009, 113(2 Pt 1):451-461.
13. Malone F.D., Canick J.A., Ball R.H., et al. First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med 2005, 353(19):2001-2011.
14. Cell-free DNA screening for fetal aneuploidy. Committee Opinion No. 640. American College of Obstetricians and Gynecologists. Obstet Gynecol 2015, 126:e31-7.
15. Langdon J.H.D. On Some of the Mental Affections of Childhood and Youth 1887, London: J & A Churchill.
16. Agathokleous M., Chaveeva P., Poon L.C., Kosinski P., Nicolaides K.H. Meta-analysis of second-trimester markers for trisomy 21. Ultrasound Obstet Gynecol 2013, 41(3):247-261.
17. Rossi A.C., Prefumo F. Accuracy of ultrasonography at 11-14 weeks of gestation for detection of fetal structural anomalies: a systematic review. Obstet Gynecol 2013, 122(6):1160-1167.
18. Hsiao C.H., Cheng P.J., Shaw S.W., et al. Extended first-trimester screening using multiple sonographic markers and maternal serum biochemistry: a five-year prospective study. Fetal Diagn Ther 2014, 35(4):296-301.
19. Sonek J.D., Cicero S., Neiger R., Nicolaides K.H. Nasal bone assessment in prenatal screening for trisomy 21. Am J Obstet Gynecol 2006, 195(5):1219-1230.
20. Keeling J.W., Hansen B.F., Kjaer I. Pattern of malformations in the axial skeleton in human trisomy 21 fetuses. Am J Med Genet 1997, 68(4):466-471.
21. Tuxen A., Keeling J.W., Reintoft I., Fischer Hansen B., Nolting D., Kjaer I. A histological and radiological investigation of the nasal bone in fetuses with Down syndrome. Ultrasound Obstet Gynecol 2003, 22(1):22-26.
22. Cicero S., Avgidou K., Rembouskos K., Kagan K.O., Nicolaides K.H. Nasal bone in first-trimester screening for trisomy 21. Am J Obstet Gynecol 2006, 195(1):109-114.
23. Cicero S., Bindra R., Rembouskos G., Spencer K., Nicolaides K.H. Integrated ultrasound and biochemical screening for trisomy 21 using fetal nuchal translucency, absent fetal nasal bone, free beta-hCG and PAPP-A at 11 to 14 weeks. Prenat Diagn 2003, 23(4):306-310.
24. Cicero S., Rembouskos G., Vandecruys H., Hogg M., Nicolaides K.H. Likelihood ratio for trisomy 21 in fetuses with absent nasal bone at the 11-14-week scan. Ultrasound Obstet Gynecol 2004, 23(3):218-223.
25. Has R., Kalelioglu I., Yuksel A., Ibrahimoglu L., Ermis H., Yildirim A. Fetal nasal bone assessment in first trimester down syndrome screening. Fetal Diagn Ther 2008, 24(1):61-66.
26. Malone F.D., Ball R.H., Nyberg D.A., et al. First-trimester nasal bone evaluation for aneuploidy in the general population. Obstet Gynecol 2004, 104(6):1222-1228.
27. Ghaffari S.R., Tahmasebpour A.R., Jamal A., et al. First-trimester screening for chromosomal abnormalities by integrated application of nuchal translucency, nasal bone, tricuspid regurgitation and ductus venosus flow combined with maternal serum free beta-hCG and PAPP-A: a 5-year prospective study. Ultrasound Obstet Gynecol 2012, 39(5):528-534.
28. Faiola S., Tsoi E., Huggon I.C., Allan L.D., Nicolaides K.H. Likelihood ratio for trisomy 21 in fetuses with tricuspid regurgitation at the 11 to 13 + 6-week scan. Ultrasound Obstet Gynecol 2005, 26(1):22-27.
29. Falcon O., Faiola S., Huggon I., Allan L., Nicolaides K.H. Fetal tricuspid regurgitation at the 11 + 0 to 13 + 6-week scan: association with chromosomal defects and reproducibility of the method. Ultrasound Obstet Gynecol 2006, 27(6):609-612.
30. Huggon I.C., DeFigueiredo D.B., Allan L.D. Tricuspid regurgitation in the diagnosis of chromosomal anomalies in the fetus at 11-14 weeks of gestation. Heart 2003, 89(9):1071-1073.
31. Kagan K.O., Valencia C., Livanos P., Wright D., Nicolaides K.H. Tricuspid regurgitation in screening for trisomies 21, 18 and 13 and Turner syndrome at 11+0 to 13+6 weeks of gestation. Ultrasound Obstet Gynecol 2009, 33(1):18-22.
32. Maiz N., Valencia C., Kagan K.O., Wright D., Nicolaides K.H. Ductus venosus Doppler in screening for trisomies 21, 18 and 13 and Turner syndrome at 11-13 weeks of gestation. Ultrasound Obstet Gynecol 2009, 33(5):512-517.
33. Prefumo F., Sethna F., Sairam S., Bhide A., Thilaganathan B. First-trimester ductus venosus, nasal bones, and Down syndrome in a high-risk population. Obstet Gynecol 2005, 105(6):1348-1354.
34. Nuchal Translucency Quality Review; 2015. Available from: . http://www.ntqr.org.
35. Nicolaides K.H. Screening for fetal aneuploidies at 11 to 13 weeks. Prenat Diagn 2011, 31(1):7-15.
36. American College of Obstetrics and Gynecologists ACOG Practice Bulletin No. 77: screening for fetal chromosomal abnormalities. Obstet Gynecol 2007, 109:217-227.
37. Wald N.J., Cuckle H., Brock J.H., Peto R., Polani P.E., Woodford F.P. Maternal serum-alpha-fetoprotein measurement in antenatal screening for anencephaly and spina bifida in early pregnancy. Report of U.K. collaborative study on alpha-fetoprotein in relation to neural-tube defects. Lancet 1977, 1(8026):1323-1332.
38. Bianchi D.W., Platt L.D., Goldberg J.D., et al. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstet Gynecol 2012, 119(5):890-901.
39. Norton M.E., Brar H., Weiss J., et al. Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18. Am J Obstet Gynecol 2012, 207(2):137e1-137e8.
40. Nicolaides K.H., Syngelaki A., Ashoor G., Birdir C., Touzet G. Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population. Am J Obstet Gynecol 2012, 207(5):374e1-374e6.
41. Platt L.D., Janicki M.B., Prosen T., et al. Impact of noninvasive prenatal testing in regionally dispersed medical centers in the United States. Am J Obstet Gynecol 2014, 211(4):368e1-368e7.
42. Benacerraf B.R., Frigoletto F.D., Laboda L.A. Sonographic diagnosis of Down syndrome in the second trimester. Am J Obstet Gynecol 1985, 153(1):49-52.
43. Copel J.A., D'Alton M.E., Gratacos E., Platt L.D., Tutschek B., Feltovich H., Odibo A.O. Obstetric Imaging 2012, Elsevier Saunders, Philadelphia, PA.
44. Morcos C.L., Platt L.D., Carlson D.E., Gregory K.D., Greene N.H., Korst L.M. The isolated choroid plexus cyst. Obstet Gynecol 1998, 92(2):232-236.
45. Platt L.D., Carlson D.E., Medearis A.L., Walla C.A. Fetal choroid plexus cysts in the second trimester of pregnancy: a cause for concern. Am J Obstet Gynecol 1991, 164(6 Pt 1):1652-1655. [discussion 1655-6].
46. Gupta J.K., Cave M., Lilford R.J., et al. Clinical significance of fetal choroid plexus cysts. Lancet 1995, 346(8977):724-729.
47. Wolburg H., Paulus W. Choroid plexus: biology and pathology. Acta Neuropathol 2010, 119(1):75-88.
48. Snijders R.J., Shawa L., Nicolaides K.H. Fetal choroid plexus cysts and trisomy 18: assessment of risk based on ultrasound findings and maternal age. Prenat Diagn 1994, 14(12):1119-1127.
49. DiPietro J.A., Costigan K.A., Cristofalo E.A., et al. Choroid plexus cysts do not affect fetal neurodevelopment. J Perinatol 2006, 26(10):622-627.
50. Twining P., Zuccollo J., Clewes J., Swallow J. Fetal choroid plexus cysts: a prospective study and review of the literature. Br J Radiol 1991, 64(758):98-102.
51. Nyberg D.A., Souter V.L., El-Bastawissi A., Young S., Luthhardt F., Luthy D.A. Isolated sonographic markers for detection of fetal Down syndrome in the second trimester of pregnancy. J Ultrasound Med 2001, 20(10):1053-1063.
52. Yoder P.R., Sabbagha R.E., Gross S.J., Zelop C.M. The second-trimester fetus with isolated choroid plexus cysts: a meta-analysis of risk of trisomies 18 and 21. Obstet Gynecol 1999, 93(5 Pt 2):869-872.
53. Gupta J.K., Khan K.S., Thornton J.G., Lilford R.J. Management of fetal choroid plexus cysts. Br J Obstet Gynaecol 1997, 104(8):881-886.
54. Brown D.L., Roberts D.J., Miller W.A. Left ventricular echogenic focus in the fetal heart: pathologic correlation. J Ultrasound Med 1994, 13(8):613-616.
55. Tennstedt C., Chaoui R., Vogel M., Goldner B., Dietel M. Pathologic correlation of sonographic echogenic foci in the fetal heart. Prenat Diagn 2000, 20(4):287-292.
56. Simpson J.M., Cook A., Sharland G. The significance of echogenic foci in the fetal heart: a prospective study of 228 cases. Ultrasound Obstet Gynecol 1996, 8(4):225-228.
57. Shipp T.D., Bromley B., Lieberman E., Benacerraf B.R. The frequency of the detection of fetal echogenic intracardiac foci with respect to maternal race. Ultrasound Obstet Gynecol 2000, 15(6):460-462.
58. Sotiriadis A., Makrydimas G., Ioannidis J.P. Diagnostic performance of intracardiac echogenic foci for Down syndrome: a meta-analysis. Obstet Gynecol 2003, 101(5 Pt 1):1009-1016.
59. Sepulveda W., Cullen S., Nicolaidis P., Hollingsworth J., Fisk N.M. Echogenic foci in the fetal heart: a marker of chromosomal abnormality. Br J Obstet Gynaecol 1995, 102(6):490-492.
60. Bromley B., Lieberman E., Shipp T.D., Richardson M., Benacerraf B.R. Significance of an echogenic intracardiac focus in fetuses at high and low risk for aneuploidy. J Ultrasound Med 1998, 17(2):127-131.
61. Benacerraf B.R., Frigoletto F.D. Soft tissue nuchal fold in the second-trimester fetus: standards for normal measurements compared with those in Down syndrome. Am J Obstet Gynecol 1987, 157(5):1146-1149.
62. Borrell A., Costa D., Martinez J.M., et al. Early midtrimester fetal nuchal thickness: effectiveness as a marker of Down syndrome. Am J Obstet Gynecol 1996, 175(1):45-49.
63. Benacerraf B.R., Barss V.A., Laboda L.A. A sonographic sign for the detection in the second trimester of the fetus with Down's syndrome. Am J Obstet Gynecol 1985, 151(8):1078-1079.
64. Crane J.P., Gray D.L. Sonographically measured nuchal skinfold thickness as a screening tool for Down syndrome: results of a prospective clinical trial. Obstet Gynecol 1991, 77(4):533-536.
65. Jelliffe-Pawlowski L.L., Walton-Haynes L., Currier R.J. Identification of second trimester screen positive pregnancies at increased risk for congenital heart defects. Prenat Diagn 2009, 29(6):570-577.
66. Nyberg D.A., Dubinsky T., Resta R.G., Mahoney B.S., Hickok D.E., Luthy D.A. Echogenic fetal bowel during the second trimester: clinical importance. Radiology 1993, 188(2):527-531.
67. Bromley B., Shipp T.D., Lyons J., Navathe R.S., Groszmann Y., Benacerraf B.R. Detection of fetal structural anomalies in a basic first-trimester screening program for aneuploidy. J Ultrasound Med 2014, 33(10):1737-1745.
68. Bromley B., Doubilet P., Frigoletto F.D., Krauss C., Estroff J.A., Benacerraf B.R. Is fetal hyperechoic bowel on second-trimester sonogram an indication for amniocentesis. Obstet Gynecol 1994, 83(5 Pt 1):647-651.
69. Sairam S., Al-Habib A., Sasson S., Thaliganathan B. Natural history of fetal hydronephrosis diagnosed on mid-trimester ultrasound. Ultrasound Obstet Gynecol 2001, 17(3):191-196.
70. Nguyen H.T., Herndon C.D., Cooper C., et al. The Society for Fetal Urology consensus statement on the evaluation and management of antenatal hydronephrosis. J Pediatr Urol 2010, 6(3):212-231.
71. Broadley P., McHugo J., Morgan I., Whittle M.J., Kilby M.D. The 4 year outcome following the demonstration of bilateral renal pelvic dilatation on pre-natal renal ultrasound. Br J Radiol 1999, 72(855):265-270.
72. Benacerraf B.R., Mandell J., Estroff J.A., Harlow B.L., Frigoletto F.D. Fetal pyelectasis: a possible association with Down syndrome. Obstet Gynecol 1990, 76(1):58-60.
73. Coco C., Jeanty P. Isolated fetal pyelectasis and chromosomal abnormalities. Am J Obstet Gynecol 2005, 193(3 Pt 1):732-738.
74. Chudleigh P.M., Chitty L.S., Pembrey M., Campbell S. The association of aneuploidy and mild fetal pyelectasis in an unselected population: the results of a multicenter study. Ultrasound Obstet Gynecol 2001, 17(3):197-202.
75. Odibo A.O., Ghidini A. Role of the second-trimester 'genetic sonogram' for Down syndrome screen in the era of first-trimester screening and noninvasive prenatal testing. Prenat Diagn 2014, 34(6):511-517.
76. Lee R.S., Cendron M., Kinnamon D.D., Nguyen H.T Antenatal hydronephrosis as a predictor of postnatal outcome: a meta-analysis. Pediatrics 2006, 118(2):586-593.
77. Rembouskos G., Cicero S., Longo D., Sacchini C., Nicolaides K.H. Single umbilical artery at 11-14 weeks' gestation: relation to chromosomal defects. Ultrasound Obstet Gynecol 2003, 22(6):567-570.
78. Dagklis T., Defigueiredo D., Staboulidou I., Casagrandi D., Nicolaides K.H. Isolated single umbilical artery and fetal karyotype. Ultrasound Obstet Gynecol 2010, 36(3):291-295.
79. Granese R., Coco C., Jeanty P. The value of single umbilical artery in the prediction of fetal aneuploidy: findings in 12,672 pregnant women. Ultrasound Q 2007, 23(2):117-121.
80. Bombrys A.E., Neiger R., Hawkins S., et al. Pregnancy outcome in isolated single umbilical artery. Am J Perinatol 2008, 25(4):239-242.
81. Burshtein S., Levy A., Holcberg G., Zlotnik A., Sheiner E. Is single umbilical artery an independent risk factor for perinatal mortality. Arch Gynecol Obstet 2011, 283(2):191-194.
82. Lubusky M., Dhaifalah I., Prochazka M., et al. Single umbilical artery and its siding in the second trimester of pregnancy: relation to chromosomal defects. Prenat Diagn 2007, 27(4):327-331.
83. DeFigueiredo D., Dagklis T., Zidere V., Allan L., Nicolaides K.H. Isolated single umbilical artery: need for specialist fetal echocardiography. Ultrasound Obstet Gynecol 2010, 36(5):553-555.
84. Nyberg D.A., Resta R.G., Luthy D.A., Hickok D.E., Williams M.A. Humerus and femur length shortening in the detection of Down's syndrome. Am J Obstet Gynecol 1993, 168(2):534-538.
85. Johnson M.P., Michaelson J.E., Barr M., et al. Combining humerus and femur length for improved ultrasonographic identification of pregnancies at increased risk for trisomy 21. Am J Obstet Gynecol 1995, 172(4 Pt 1):1229-1235.
86. Benacerraf B.R., Neuberg D., Frigoletto F.D. Humeral shortening in second-trimester fetuses with Down syndrome. Obstet Gynecol 1991, 77(2):223-227.
87. Bahado-Singh R.O., Deren O., Tan A., et al. Ultrasonographically adjusted midtrimester risk of trisomy 21 and significant chromosomal defects in advanced maternal age. Am J Obstet Gynecol 1996, 175(6):1563-1568.
88. Rodis J.F., Vintzileos A.M., Fleming A.D., et al. Comparison of humerus length with femur length in fetuses with Down syndrome. Am J Obstet Gynecol 1991, 165(4 Pt 1):1051-1056.
89. Larion S., Warsof S.L., Romary L., Mlynarczyk M., Peleg D., Abuhamad A.Z. Uptake of noninvasive prenatal testing at a large academic referral center. Am J Obstet Gynecol 2014, 211(6):651e1-651e7.
90. Donnelly J.C., Platt L.D., Rebarber A., Zachary J., Grobman W.A., Wapner R.J. Association of copy number variants with specific ultrasonographically detected fetal anomalies. Obstet Gynecol 2014, 124(1):83-90.